Let's Talk Nail Talk, Inc. – Trademark Portfolio
Entity Type: 03
Let's Talk Nail Talk, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LET'S TALK NAIL TALK, INC. and LTNT LET'S TALK NAIL TALK INC.. The owner is based in Oak Park, IL.
159 N Marion St., 271
Oak Park, IL 60301
Showing of trademarks Trademarks
Trademark Classifications
Let's Talk Nail Talk, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Let's Talk Nail Talk, Inc. have?
Let's Talk Nail Talk, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Let's Talk Nail Talk, Inc. file in?
Let's Talk Nail Talk, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Let's Talk Nail Talk, Inc.'s most well-known trademarks?
Let's Talk Nail Talk, Inc.'s registered trademark portfolio includes well-known marks such as LET'S TALK NAIL TALK, INC. and LTNT LET'S TALK NAIL TALK INC.. These are among 2 currently registered trademarks in the portfolio.
What is Let's Talk Nail Talk, Inc.'s trademark registration success rate?
Let's Talk Nail Talk, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.